Skip to Content

TEVA 22 10 (Sucralfate 1 g)

Pill with imprint TEVA 22 10 is White, Capsule-shape and has been identified as Sucralfate 1 g. It is supplied by Teva Pharmaceuticals USA.

Sucralfate is used in the treatment of gerd; duodenal ulcer; duodenal ulcer prophylaxis; hyperphosphatemia of renal failure; stomatitis (and more), and belongs to the drug class miscellaneous GI agents. There is no proven risk in humans during pregnancy. Sucralfate 1 g is not a controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 22 10

Sucralfate 1 g TEVA 22 10 Front
Sucralfate 1 g TEVA 22 10 Back
Sucralfate 1 g TEVA 22 10
Sucralfate 1 g TEVA 22 10
Sucralfate 1 g TEVA 22 10


TEVA 22 10
1 g
Prescription only
Drug Class:
Miscellaneous GI agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.